Urinary PC-1 and N-acetyl-β-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide

Annals of Clinical Biochemistry

Volumn 40, Issue 3, 2003, Pages 232-234

  Stefanović, Vladisav ^a   Antic S ^b   Mitic Zlatkovic M ^b   Stojiljkovic S ^a   Milojkovic M ^a   Bogicevic M ^a   Vlahovic P ^a  

^a Inst of Nephrology and Hemodialysis   (Yugoslavia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; GLIBENCLAMIDE; GLICLAZIDE; GLYCOPROTEIN; LYSOSOME ENZYME; MEMBRANE PROTEIN; METFORMIN; N ACETYL BETA GLUCOSAMINIDASE; ORAL ANTIDIABETIC AGENT; PLASMA CELL DIFFERENTIATION ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; KIDNEY TUBULE DAMAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; URINALYSIS; URINARY EXCRETION;

ACETYLGLUCOSAMINIDASE; ADMINISTRATION, ORAL; ADULT; AGED; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; GLICLAZIDE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; OBESITY; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES;

EID: 0038366556     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456303321610510     Document Type: Article

References (12)

1. Maddux BA, Sbraccia P, Kamakura S, Sasson S, Youngren J, Fisher A, et al. Membrane glycoprotein PC-1 and insulin resistance in noninsulin-dependent diabetes mellitus. Nature 1995; 373: 448-51
2. Stefanović V, Antić S, Mitić-Zlatković M, Vlahović P. Reversal of lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin. Diabetes Metab Res Rev 1999; 15: 400-5
3. Haugen HF, Skrede S. Nucleotide pyrophosphatase and phosphodiesterase. I. Organ distribution and activities in body fluids. Clin Chem 1977; 23: 1531-7
4. Stefanović V, Milojković M, Mitić-Zlatković M, Antić S, Ivić M, Vlahović P. Plasma and urine PC-1 activity in type 2 diabetics treated with metformin. Facta Universitatis 2001; 8: 59-62
5. Jones AP, Lock S, Griffiths KD. Urinary N-acetyl-β-glucosaminidase activity in type I diabetes mellitus. Ann Clin Biochem 1995; 32: 58-62
6. Mocan Z, Erem C, Yildirim M, Telatar M, Deger C. Urinary β 2-microglobulin levels and urinary N-acetyl-β-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy. Diabetes Res 1994; 26: 101-7
7. Horak E, Hopfer SM, Sunderman W. Spectrophotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin Chem 1981; 27: 1180-5
8. Stefanović V, Rajić M, Antić S, Mitić-Zlatković M, Stojiljković S, Ivić MA, et al. Urinary PC-1 activity in patients with type 1 diabetes mellitus. Ann Clin Biochem 2003; 40: 235-8
9. Weitgasser R, Schnoell F, Gappmayer B, Kartnig L. Prospective evaluation of urinary N-acetyl-β-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care 1999; 22: 1882-6
10. Hong CY, Chia KS, Ling SL. Urinary protein excretion in type 2 diabetes with complications. J Diabetes Complications 2000; 14: 259-65
11. Amador-Licona R, Guizar-Mendoza J, Vargas E, Sanchez-Camargo G, Zamora-Malta L. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus. Arch Med Res 2000; 31: 571-5
12. Engbersen R, Moons NM, Wouterse AC, Dijkman HB, Kramers C, Smits P, et al. Sulphonylurea drugs reduce hypoxic damage in the isolated perfused rat kidney. Br J Pharmacol 2000; 130: 1678-84